- Report
- May 2025
- 200 Pages
Global
From €2209EUR$2,490USD£1,918GBP
- Report
- February 2025
- 135 Pages
Global
From €2209EUR$2,490USD£1,918GBP
- Report
- June 2025
- 208 Pages
Global
From €2218EUR$2,500USD£1,925GBP
- Report
- April 2025
- 233 Pages
Global
From €2218EUR$2,500USD£1,925GBP
- Report
- April 2025
- 239 Pages
Global
From €2218EUR$2,500USD£1,925GBP
- Report
- November 2024
- 164 Pages
Global
From €2218EUR$2,500USD£1,925GBP
- Report
- November 2024
- 165 Pages
Global
From €2218EUR$2,500USD£1,925GBP
- Report
- February 2025
- 341 Pages
Global
From €3592EUR$4,050USD£3,119GBP
- Report
- October 2025
- 378 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 414 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 154 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 200 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- September 2025
- 250 Pages
Global
From €3983EUR$4,490USD£3,458GBP
- Report
- April 2025
- 200 Pages
Global
From €3983EUR$4,490USD£3,458GBP
- Report
- April 2025
- 200 Pages
Global
From €3983EUR$4,490USD£3,458GBP
- Report
- September 2025
- 185 Pages
Global
From €3992EUR$4,500USD£3,466GBP
- Report
- August 2025
- 185 Pages
Global
From €3992EUR$4,500USD£3,466GBP
- Report
- August 2025
- 180 Pages
Global
From €3992EUR$4,500USD£3,466GBP
- Report
- July 2025
- 188 Pages
Global
From €3992EUR$4,500USD£3,466GBP
- Report
- July 2025
- 188 Pages
Global
From €3992EUR$4,500USD£3,466GBP

The Genetic Disease market is a subset of the Genomics market that focuses on the diagnosis, treatment, and prevention of genetic diseases. It is a rapidly growing field, driven by advances in technology and the increasing availability of genetic testing. Companies in this market are developing new treatments and therapies for genetic diseases, as well as diagnostic tests and tools to identify and monitor them. They are also researching ways to prevent genetic diseases from occurring in the first place.
Companies in the Genetic Disease market include Illumina, Thermo Fisher Scientific, BGI, Genomic Health, and Invitae. These companies are developing innovative products and services to help diagnose, treat, and prevent genetic diseases. They are also investing in research and development to further advance the field. Show Less Read more